TypeSafe AI
Developer infrastructure that turns unstructured inputs into typed decisions and probability scores for automated software workflows.
$870MSeries A
ParticipantD
DCVC
Activity from announced rounds
Activity in this selectionAI
DCVC is an investment firm identified by TypeSafe AI as an existing investor and by its own communications as a backer of Shennon Biotechnologies.
Recorded funding activity
TypeSafe turns unstructured inputs into typed decisions and probability scores for automated software. Shennon develops T-cell engager therapies for solid tumors. Separate TypeSafe financings remain separate events under one investor history.
Sources
- Rounds participated in
- 8
- Confirmed lead rounds
- 1 6 roles undisclosed
- New companies
- 7 First participation on record · 1 follow-on
- Funding in participating rounds
- $1.4B 7 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
8 in this selectionTypeSafe AI
Developer infrastructure that turns unstructured inputs into typed decisions and probability scores for automated software workflows.
$40MSeed
LeadCallosum
Software infrastructure allowing AI workloads to run across different chips and models
$100MSeed
Role not disclosedSabanto
Sabanto develops autonomous retrofit technology for agricultural equipment.
UndisclosedSeries B
Role not disclosedKanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosedHalter
Develops GPS-enabled cattle collars using sensors, software and AI.
$220MSeries E
Role not disclosedChariot Defense
Chariot Defense develops power-distribution systems for military use.
$34MSeries A
Role not disclosedProxima
Develops AI-driven drug discovery for proximity therapeutics
$80MUndisclosed
Role not disclosed